OGDHL promotes prostate cancer progression and regulates neuroendocrine marker expression and nucleotide abundance

By afschroeder • January 28, 2026

Bernard MJ, Gallardo A, Ruiz A, Diaz JA, Nunley NM, Dove RN, Zhang S, Lee E, Heering KY, Varuzhanyan G, Bopardikar S, Hashimoto T, Agrawal R, Smith CM, Wilde BR, Matulionis N, Richards HM, Lee SCS, Sharifi MN, Lang JM, Zhao SG, Witte ON, Haffner MC, Shackelford DB, Boutros PC, Christofk HR, Goldstein AS. OGDHL promotes prostate cancer progression and regulates neuroendocrine marker expression and nucleotide abundance. Mol Cancer Res. 2026 Jan 27. doi: 10.1158/1541-7786.MCR-25-0913. Epub ahead of print. PMID: 41591383.

Tags: Publications, Pulmonary, Critical Care & Sleep Medicine

Implantable Cardioverter-Defibrillator Therapy in Patients With Transposition of the Great Arteries: A Systematic Review of the Literature

Yao JV, Cid-Serra X, Albadosh K, Browne A, Egorova AD, Ladouceur M, Broberg C, Nizam MA, Khairy P, Padfield GJ, Moore JP, Kandavello G, Reddy[...]

Impacts of neutralizing antibody responses on SARS-CoV-2 evolution and its associated disease progression

Wang L, Aliyari S, Sands N, Lee B, Yu A, Xia S, Jolkovsky EL, Zhang S, Kim J, Cheng G. Impacts of neutralizing antibody responses[...]

Artificial Intelligence-derived Measurements of Myosteatosis from Coronary Artery Calcium CT Scans to Predict COPD: The Multi-Ethnic Study of Atherosclerosis

Azimi A, Atlas K, Reeves AP, Zhang C, Wasserthal J, Mirjalili SR, Atlas T, Henschke CI, Yankelevitz DF, Zulueta JJ, de-Torres JP, Seijo LM, Mechanick[...]